https://www.thebodypro.com/category/hiv-policy-advocacy/tag/news

The Latest

dapivirine vaginal ring

This Week in HIV Research: Where the Rubber Meets the Ring

Sept. 10, 2020: Concomitant use of vaginal rings with condoms; benefits of more frequent HIV screening for young MSM; Black MSM, substance use, and the PrEP continuum; HIV outcomes stratified by anti-LGTBQ policy across U.S. states.

By Barbara Jungwirth and Myles Helfand
Peter Stinner with his husband, Jeff Graham.

Remembering Peter Stinner, a Keystone of Atlanta’s HIV Community

Stinner's husband, Jeff Graham, and colleague, Jonathan Colasanti, M.D., share a trove of stories about a person who embodied the ideals of empathy and care in HIV and health services.

By Terri Wilder, M.S.W.
Wakefield headshot.

This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect

Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.

By Kenyon Farrow
LaRon Nelson headshot.

COVID-19 (and HIV) Disparities Are About Racism, Not Race. This Nurse Explains How

LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.

By Terri Wilder, M.S.W.
staying in touch

HIV Care and Coronavirus (COVID-19): The Latest Info and Guidance

Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.

By Myles Helfand and Sony Salzman
integrase inhibitor

This Week in HIV Research: The Fast-Acting Power of Integrase

April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.

By Barbara Jungwirth and Myles Helfand
Jesse Milan

Due to Coronavirus, a Virtual AIDSWatch 2020 Happened This Week—and Set a Record for Number of Attendees

AIDS United quickly revised the conference when it became clear that the COVID-19 crisis would shut down the longstanding IRL version.

By Tim Murphy
woman in headscarf receiving chemotherapy in yellow room

This Week in HIV Research: A New Year, an Old Enemy

Jan. 2, 2020: Cancer treatment among people with HIV in the Obamacare era; chemotherapy, CD4 count, and mortality; cutting meds to cut costs; tailoring interventions on the microepidemic level.

By Barbara Jungwirth and Myles Helfand
Doctors from HIVMA and IDSA on Capitol Hill

Doctors Meet With Congressional Staff to Push for 'Ending the HIV Epidemic' Budget

At IDWeek in Washington, D.C., leading infectious disease doctors and researchers met with U.S. Congress leadership to discuss HIV prevention, treatment, and care policy.

By Sony Salzman
Washington DC at sunset, including Washington Monument

IDWeek 2019: What to Expect at This Year's Conference

We're covering the latest news and research from this major interdisciplinary meeting on infectious diseases, which takes place in Washington, D.C., from Oct. 2 to Oct. 6.

By Sony Salzman